Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical Differentiation of Severe Fever with Thrombocytopenia Syndrome from Japanese Spotted Fever.
Nakada N, Yamamoto K, Tanaka M, Ashizawa H, Yoshida M, Umemura A, Fukuda Y, Katoh S, Sumiyoshi M, Mihara S, Kobayashi T, Ito Y, Ashizawa N, Takeda K, Ide S, Iwanaga N, Takazono T, Tashiro M, Tanaka T, Nakamichi S, Morimoto K, Ariyoshi K, Morita K, Kurihara S, Yanagihara K, Furumoto A, Izumikawa K, Mukae H. Nakada N, et al. Among authors: furumoto a. Viruses. 2022 Aug 18;14(8):1807. doi: 10.3390/v14081807. Viruses. 2022. PMID: 36016429 Free PMC article.
A case series of histoplasmosis patients with elevated serum soluble interleukin-2 receptor levels.
Hirayama T, Takazono T, Iwata K, Senju H, Shimazaki T, Tashiro M, Saijo T, Tanaka T, Nakamura S, Imamura Y, Kojiro M, Miyazaki T, Tsukamoto M, Furumoto A, Morimoto K, Muraosa Y, Matsubara Y, Yanagihara K, Mukae H, Kamei K, Kohno S, Izumikawa K. Hirayama T, et al. Among authors: furumoto a. J Infect Chemother. 2017 Sep;23(9):642-647. doi: 10.1016/j.jiac.2017.03.006. Epub 2017 Apr 8. J Infect Chemother. 2017. PMID: 28395939
Accuracy of High-Throughput Nanofluidic PCR-Based Pneumococcal Serotyping and Quantification Assays Using Sputum Samples for Diagnosing Vaccine Serotype Pneumococcal Pneumonia: Analyses by Composite Diagnostic Standards and Bayesian Latent Class Models.
Kakiuchi S, Suzuki M, Dhoubhadel BG, Furumoto A, Ito H, Matsuki K, Tsuchihashi Y, Asoh N, Yasunami M, Ariyoshi K, Morimoto K. Kakiuchi S, et al. Among authors: furumoto a. J Clin Microbiol. 2018 Apr 25;56(5):e01874-17. doi: 10.1128/JCM.01874-17. Print 2018 May. J Clin Microbiol. 2018. PMID: 29444834 Free PMC article.
Impact of the pediatric 13-valent pneumococcal conjugate vaccine on serotype distribution and clinical characteristics of pneumococcal pneumonia in adults: The Japan Pneumococcal Vaccine Effectiveness Study (J-PAVE).
Sando E, Suzuki M, Furumoto A, Asoh N, Yaegashi M, Aoshima M, Ishida M, Hamaguchi S, Otsuka Y, Morimoto K. Sando E, et al. Among authors: furumoto a. Vaccine. 2019 May 6;37(20):2687-2693. doi: 10.1016/j.vaccine.2019.04.009. Epub 2019 Apr 8. Vaccine. 2019. PMID: 30975569
Corrigendum to "Impact of the pediatric 13-valent pneumococcal conjugate vaccine on serotype distribution and clinical characteristics of pneumococcal pneumonia in adults: The Japan Pneumococcal Vaccine Effectiveness Study (J-PAVE)" [Vaccine 37 (2019) 2687-2693].
Sando E, Suzuki M, Furumoto A, Asoh N, Yaegashi M, Aoshima M, Ishida M, Hamaguchi S, Otsuka Y, Morimoto K. Sando E, et al. Among authors: furumoto a. Vaccine. 2020 Apr 9;38(17):3404. doi: 10.1016/j.vaccine.2020.03.031. Epub 2020 Mar 19. Vaccine. 2020. PMID: 32201139 No abstract available.
Long-term impact of pneumococcal conjugate vaccines for children on adult pneumococcal pneumonia in Japan: Two multicenter observational studies from 2011 to 2020.
Maeda H, Gopal Dhoubhadel B, Sando E, Suzuki M, Furumoto A, Asoh N, Yaegashi M, Aoshima M, Ishida M, Hamaguchi S, Otsuka Y, Morimoto K. Maeda H, et al. Among authors: furumoto a. Vaccine. 2022 Sep 2;40(37):5504-5512. doi: 10.1016/j.vaccine.2022.07.041. Epub 2022 Aug 10. Vaccine. 2022. PMID: 35963821
Evaluation of a Triage Checklist for Mild COVID-19 Outpatients in Predicting Subsequent Emergency Department Visits and Hospitalization during the Isolation Period: A Single-Center Retrospective Study.
Tanaka Y, Yamamoto K, Morimoto S, Nabeshima T, Matsushima K, Ishimoto H, Ashizawa N, Hirayama T, Takeda K, Gyotoku H, Iwanaga N, Takemoto S, Fukahori S, Takazono T, Yamaguchi H, Kido T, Sakamoto N, Hosogaya N, Akabame S, Sugimoto T, Yamanashi H, Matsui K, Izumida M, Fujita A, Tashiro M, Tanaka T, Ariyoshi K, Furumoto A, Morita K, Izumikawa K, Yanagihara K, Mukae H. Tanaka Y, et al. Among authors: furumoto a. J Clin Med. 2022 Sep 16;11(18):5444. doi: 10.3390/jcm11185444. J Clin Med. 2022. PMID: 36143099 Free PMC article.
Serological response to a third dose of SARS-CoV-2 vaccine according to previous infection history.
Ota K, Murakami S, Ishihara K, Sasaki D, Usui T, Mitsumoto-Kaseida F, Sakamoto K, Kosai K, Hasegawa H, Takazono T, Furumoto A, Asoh N, Yoshimine H, Sawai T, Onizuka M, Makimoto N, Izumikawa K, Mukae H, Kohno S, Yanagihara K. Ota K, et al. Among authors: furumoto a. Vaccine X. 2023 Apr;13:100282. doi: 10.1016/j.jvacx.2023.100282. Epub 2023 Mar 17. Vaccine X. 2023. PMID: 36960104 Free PMC article.
53 results